ITMCTR2000003683尚未招募1 期
Effect of Shenqing capsule on inducing mild to moderate active ulcerative colitis: a multicenter, randomized, double-blinded, parallelly positive controlled study
onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70（—）
- 性别
- All
入选标准
- •1) active ulcerative colitis (mild to moderate), Mayo score >= 3;
- •2) the subjects between 18 and 70 years, male or female;
- •3) the subjects informed consent and signed the informed consent form.
排除标准
- •1) severe ulcerative colitis or acute severe ulcerative colitis.
- •2) ulcerative proctitis.
- •3) patients with complications, such as intestinal obstruction, intestinal perforation, massive hemorrhage of lower digestive tract or perianal diseases.
- •4) pathological biopsy of colonic mucosa showed dysplasia or suspected carcinoma.
- •5) extra-colonic manifestations, such as skin and mucosal manifestations (oral ulcer, nodular erythema and pyoderma gangrenosum), joint lesions (such as peripheral arthritis, spinal arthritis, etc.), eye lesions (such as iritis, scleritis, uveitis, etc.), hepatobiliary diseases (such as primary sclerosing cholangitis, etc.), thromboembolic disease.
- •6) confirmed or suspected bacillary dysentery, amoebic dysentery, intestinal schistosomiasis, intestinal tuberculosis, fungal colitis, antibiotic-associated colitis, eosinophilic colitis, Behcet's disease, Crohn's disease, ischemic enteritis, radiation enteritis, undetermined colitis, colonic diverticulitis, etc.
- •7) 5-aminosalicylic acid and hormone were used in the past 1 month, immunosuppressants and biological agents were used in the last 3 months, etc.
- •8) complicated with severe respiratory, circulatory, endocrine, blood, urinary, neurological or other digestive diseases, malignant tumors.
- •9) the upper limit of serum creatinine > normal reference value, alanine aminotransferase, aspartate aminotransferase > 2x normal upper limits.
- •10) pregnant or lactating women, patients with recent fertility plans.
- •11) allergic constitution, history of allergy to mesalazine, Shenqing capsule or any excipients.
- •12) those who suspect or do have a history of alcohol or drug abuse.
- •13) those who have a history of anxiety or depression and need to take medication, or who have a history of mental illness.
- •14) according to the researcher's judgment, the subjects who has other conditions which are not suitable to participate in this clincial trial.
研究者
相似试验
尚未招募
4 期
Clinical study for the effect of Zhenyuan capsule on Cardiopulmonary function in patients with stable Coronary Heart Disease with Qi deficiency and Blood stasisITMCTR2000003300Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine
招募中
不适用
Clinical study on the effect of Sansang Shenqi Decoction on airway function in patients with chronic obstructive pulmonary disease at stable periodITMCTR2000003723ongHua Hospital Shanghai University of Traditional Chinese Medicine
招募中
1 期
Effects of Shenlingbaizhu powder on the efficacy of chemotherapy and the quality of life of patients with ovarian cancer based on intestinal microecologyOvarian cancerITMCTR2100004792The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
尚未招募
4 期
Clinical Observation of Shengui Capsule Intervention in Heart Failure with Preserved Ejection Fractioheart failure with preserved ejection fractionITMCTR2200005794Dongzhimen Hospital, Beijing University of Chinese Medicine
尚未招募
4 期
A clinical study of Quanduzhong capsule in treating primary osteoporosis (kidney-yang deficiency syndrome)ITMCTR2100005285Wangjing Hospital of China Academy of Chinese Medical Sciences